跳至主要内容
临床试验/JPRN-UMIN000019347
JPRN-UMIN000019347已完成未知

Evaluation of efficacy and safety in bFGF injection to treat severe vocal fold lesions and vocal fold paralysis. - bFGF injection for vocal fold lesions.

Tokyo Voice Center, International University of Health and Welfare0 个研究点目标入组 12 人开始时间: 2015年10月16日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
12

研究概览

简要总结

Results: No adverse events were recorded. Significant improvements were observed in the maximum phonation time (MPT) and Voice Handicap Index (VHI) after treatment. Multiple injections achieved additional effects. Conclusions and significance: bFGF injection may be a safe and suitable office-based surgery for the alleviation of hoarseness caused by SV based on this preliminary short-term study.

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • The subjects with obvious decrease in cardiac function, respiratory function, or hepatic dysfunction in preoperative examinations such as blood sampling, electrocardiogram, or chest x-ray within 3 months. The subjects with vital signs such as heart rate, blood oxygen saturation, and blood pressure are abnormal on the day of surgery. The subjects with other laryngeal disease. The subjects with a history of laryngeal cancer The subjects with drug allergy

研究者

发起方
Tokyo Voice Center, International University of Health and Welfare

相似试验

Evaluation of efficacy and safety in bFGF injection... | 临床试验